Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
US Department of Justice
Johnson and Johnson

Generated: August 19, 2017

DrugPatentWatch Database Preview

AMINOSYN II 5% Drug Profile

« Back to Dashboard

What is the patent landscape for Aminosyn Ii 5%, and when can generic versions of Aminosyn Ii 5% launch?

Aminosyn Ii 5% is a drug marketed by Icu Medical Inc, Abbott, Hospira, and Hospira Inc. and is included in six NDAs.

The generic ingredient in AMINOSYN II 5% is amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and thirty-nine drug master file entries for this compound. Additional details are available on the amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride profile page.

Summary for Tradename: AMINOSYN II 5%

Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMINOSYN II 5% at DailyMed

Pharmacology for Tradename: AMINOSYN II 5%

Ingredient-typeAmino Acids
Drug ClassAmino Acid
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Harvard Business School
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus